Sort   by:  
 Page size 
Background: Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia. Objectives: To conduct proteomic studies i...
ORGANISM(S): Homo sapiens (Human) 
2020-11-16 | PXD021642 | Pride
Sort   by:  
 Page size